EVOQ Remedies Ltd. Stock Analysis 543500.BO

Evoq Remedies Ltd. engages in the provision of pharmaceutical raw materials. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2022-03-30. The firm is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. The company offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. The firm also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulfate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam, Amoxycillin Trihydrate, Ampicillin Trihydrate, Artemether, Finasteride, Imipramine, Lidocaine, and more.